Jinbiao Zhong
Overview
Explore the profile of Jinbiao Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding H, Ding H, Zhang F, Zhong J, Pan J, Chen Y, et al.
Front Cardiovasc Med
. 2024 Dec;
11:1337243.
PMID: 39624220
Background: Pulmonary hypertension (PH) in patients with end-stage renal disease (ESRD) has a high incidence rate and mortality and its early identification is critical. However, whether a combination of clinical,...
2.
Pan J, Zheng Z, Wang W, Hu D, Yao R, Chen Y, et al.
BMC Infect Dis
. 2024 Jul;
24(1):728.
PMID: 39048969
Background And Intention: Erectile dysfunction (ED) is an underappreciated clinical condition in men. This study aims to compare the dynamic changes in the distribution of ED among male kidney transplant...
3.
Zhang F, Wang W, Zhong J, Ding H, Liao G, Liang C
BMC Microbiol
. 2024 May;
24(1):189.
PMID: 38811884
Background: The study aims to analyze the epidemiology of preservation fluid (PF) contamination and investigate the impact of PF contamination and possible donor-derived infections(p-DDI) on early postoperative prognosis in kidney...
4.
Zhang F, Li P, Zhong J, Ding H, Liao G, Liang C
Front Cell Infect Microbiol
. 2024 May;
14:1404404.
PMID: 38779560
Background: Ceftazidime-avibactam is a treatment option for carbapenem-resistant gram-negative bacilli (CR-GNB) infections. However, the risk factors associated with ceftazidime-avibactam (CAZ-AVI) treatment failure in kidney transplant (KT) recipients and the need...
5.
Liao G, Chen F, Zhong J, Jiang X
Mol Med Rep
. 2024 May;
30(1).
PMID: 38757308
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion assay data shown in Fig. 2C on...
6.
Zhou X, Lai W, Zhong J, Yang Y, Chen Z, Zhang C
Anal Chim Acta
. 2023 Oct;
1279:341829.
PMID: 37827624
As a good biomarker to reflect the average level of blood glucose, glycated hemoglobin (HbA1c) is mainly used for long-term glycemic monitoring and risk assessment of complications in diabetic patients....
7.
Lai W, Shi Y, Zhong J, Zhou X, Yang Y, Chen Z, et al.
Talanta
. 2023 Feb;
256:124287.
PMID: 36738623
Liver disease causes serious public health problems because of its high prevalence, particularly affecting low- and middle-income countries. Alanine transaminase (ALT) is considered to be one of the most sensitive...
8.
Zhang F, Zhong J, Ding H, Liao G
BMC Nephrol
. 2022 Mar;
23(1):101.
PMID: 35287599
Background: Infections remain a major cause of morbidity and mortality in kidney transplant (KT) recipients. This study aimed to investigate the preservation fluid (PF) samples from deceased donors and report...
9.
Zhang F, Zhong J, Ding H, Liao G
Infect Drug Resist
. 2021 Dec;
14:5165-5174.
PMID: 34908850
Purpose: The clinical efficacy of ceftazidime-avibactam (CAZ-AVI) in treating carbapenem-resistant (CRKP)-infected recipients after kidney transplantation (KT) has not been well evaluated. We aimed to assess its efficacy in a single-center...
10.
Zhang F, Zhong J, Ding H, Pan J, Yang J, Lan T, et al.
Front Cell Infect Microbiol
. 2021 Oct;
11:726282.
PMID: 34692560
Background: Infections remain a major cause of morbidity and mortality in kidney transplant (KT) recipients. This study was performed to identify the overall prevalence of early infections, prevalence of carbapenem-resistant...